PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | C1561644|chronic kidney disease (ckd) |
| Sentences | 50 |
| PubMedID- 21562144 | Background: markers of collagen turnover have not been well studied in the context of cardiovascular disease in patients with chronic kidney disease (ckd). |
| PubMedID- 23338722 | chronic kidney disease (ckd) is associated with accelerated cardiovascular disease (cvd) risk and a higher cvd event rate. |
| PubMedID- 21595847 | Vascular calcification is the most important cause of cardiovascular disease in patients with chronic kidney disease (ckd). |
| PubMedID- 23120811 | High incidence of cardiovascular diseases in patients with chronic kidney disease (ckd) can not soley be explained by traditional risk factors. |
| PubMedID- 23095239 | Cardiovascular disease is increased in patients with chronic kidney disease (ckd) and is the principle cause of morbidity and mortality in these patients. |
| PubMedID- 21111939 | Background: endothelial dysfunction (ed) is closely linked to cardiovascular disease and outcome in patients with chronic kidney disease (ckd). |
| PubMedID- 20682604 | Background: inflammation and chronic kidney disease (ckd) are both associated with cardiovascular disease (cvd). |
| PubMedID- 22349087 | chronic kidney disease (ckd) is strongly associated with cardiovascular disease (cvd); a graded inverse relationship between estimated glomerular filtration rate (egfr) and cardiovascular event rates has emerged from large-scale observational studies. |
| PubMedID- 24434383 | Knowledge of the epidemiology and risk profile of peripheral vascular disease among patients with chronic kidney disease (ckd) has a potential role for determining its outcome. |
| PubMedID- 24018401 | Traditional risk factors do not account for increased cardiovascular disease in patients with chronic kidney disease (ckd), particularly individuals whose ckd has progressed to end-stage kidney disease requiring dialysis. |
| PubMedID- 22822101 | Aims: increased serum phosphorus levels are associated with cardiovascular disease in patients with chronic kidney disease (ckd) and in the general population. |
| PubMedID- 26374599 | Insulin resistance (ir) is a novel cardiovascular risk factor that has been implicated in the pathogenesis of cardiovascular disease (cvd) in patients with chronic kidney disease (ckd). |
| PubMedID- 26215643 | Serum phosphorus level is a risk factor for cardiovascular disease in patients with chronic kidney disease (ckd) [1–3]. |
| PubMedID- 23451044 | The high prevalence of cardiovascular disease in chronic kidney disease (ckd) stage 5 d, i.e. |
| PubMedID- 20347511 | Background: vascular calcification contributes to cardiovascular disease in patients with chronic kidney disease (ckd). |
| PubMedID- 25923753 | Introduction: metabolic syndrome (ms) has a high prevalence in hemodialysis' patients and is a risk factor for cardiovascular disease, the leading cause of mortality in chronic kidney disease (ckd). |
| PubMedID- 25874106 | Therefore, hyperphosphataemia is a widely recognized risk factor for mortality and cardiovascular disease in patients with chronic kidney disease (ckd) [1]. |
| PubMedID- 23190513 | chronic kidney disease (ckd) increases the risk of developing cardiovascular diseases such as heart failure (hf) and ischemic heart disease (ihd). |
| PubMedID- 22244796 | Background: accelerated vascular calcification contributes to cardiovascular disease burden in patients with chronic kidney disease (ckd). |
| PubMedID- 23113674 | Aim: the current data have proven the pivotal role of inflammation in the development of atherosclerosis and cardiovascular diseases in patients with chronic kidney disease (ckd). |
| PubMedID- 20172445 | Background: elderly individuals with chronic kidney disease (ckd) have high rates of comorbid conditions, including cardiovascular disease and its risk factors, and ckd-related complications. |
| PubMedID- 21876352 | Background: cardiovascular disease in chronic kidney disease (ckd) has peculiar characteristics. |
| PubMedID- 26483371 | chronic kidney disease (ckd) increases the risk of all-cause mortality and cardiovascular disease as well as progression to end stage kidney failure. |
| PubMedID- 22470397 | Proteinuria is an important risk factor not only for progression of renal failure but also for the development of cardiovascular disease in patients with chronic kidney disease (ckd) [17]. |
| PubMedID- 24966085 | Reduced nitric oxide (no) synthesis contributes to risk for cardiovascular disease in chronic kidney disease (ckd). |
| PubMedID- 21288351 | The risk of cardiovascular disease is elevated in patients with chronic kidney disease (ckd) with an inverse graded relationship to glomerular filtration rate (gfr) independent of other risk factors [1]. |
| PubMedID- 21629196 | The increased risk of cardiovascular disease (cvd) in patients with chronic kidney disease (ckd) has been well documented. |
| PubMedID- 26430136 | Renovascular disease (rvd) can lead to hypertension and chronic kidney disease (ckd). |
| PubMedID- 25924679 | Background: reliable estimates of the impacts of chronic kidney disease (ckd) stage, with and without cardiovascular disease, on hospital costs are needed to inform health policy. |
| PubMedID- 22160646 | Purpose: advanced glycation end products (age), biomarkers of metabolic stress, are frequently encountered in chronic kidney disease (ckd) patients with cardiovascular disease. |
| PubMedID- 24899042 | chronic kidney disease (ckd) is strongly associated with cardiovascular disease and muscle wasting, arising from numerous factors associated with declining renal function and lifestyle factors. |
| PubMedID- 21965650 | Objective: since chronic kidney disease (ckd) is closely associated with cardiovascular disease and mortality as well as endstage renal disease, prediction of progressive ckd is a clinically important issue. |
| PubMedID- 26102877 | Objective: increased risk of cardiovascular disease in patients with chronic kidney disease (ckd) has been related to vascular stiffness and isolated systolic hypertension as a result of vascular calcification due to mineral metabolism abnormalities. |
| PubMedID- 25612295 | Background: chronic kidney disease (ckd) is associated with accelerated cardiovascular disease and heart failure. |
| PubMedID- 23470818 | Purpose of review: this review will examine advances in our understanding of the association between high-density lipoprotein (hdl) function and cardiovascular disease (cvd) in patients with chronic kidney disease (ckd). |
| PubMedID- 20542859 | Background: several large prospective studies have reported that a low estimated glomerular filtration rate (egfr) or chronic kidney disease (ckd) is independently associated with cardiovascular disease (cvd) events and all-cause mortality in high-risk populations. |
| PubMedID- 26354563 | The objective of this study is to determine the prevalence of peripheral vascular disease (pvd) in patients with chronic kidney disease (ckd). |
| PubMedID- 22445470 | Background: endothelial dysfunction (ed) is a key event in the development of atherosclerotic cardiovascular disease (cvd) in patients with chronic kidney disease (ckd). |
| PubMedID- 22127399 | A plethora of evidence has indicated that strict bp reduction is indispensable to improve patients’ prognosis, inadequate control of bp is thus leaving patients at risk of cardiovascular disease, particularly in patients with chronic kidney disease (ckd) and uncontrollable hypertension [1]. |
| PubMedID- 25401485 | Background and aims: there is limited information on the risk of progression of chronic kidney disease (ckd) among individuals with cvd (cardiovascular disease). |
| PubMedID- 20346746 | chronic kidney disease (ckd) is strongly associated with cardiovascular disease. |
| PubMedID- 20576822 | Background and objectives: cardiovascular disease in chronic kidney disease (ckd) is explained in part by traditional cardiovascular risk factors; by uremia-specific factors; and by abnormalities of mineral metabolism, factors involved in its regulation, and in the vascular calcification process. |
| PubMedID- 24867675 | Purpose of review: high levels of fibroblast growth factor 23 (fgf23) cause the rare disorders of hypophosphatemic rickets and are a risk factor for cardiovascular disease and death in patients with chronic kidney disease (ckd). |
| PubMedID- 23577141 | The cardiovascular disease burden in patients with chronic kidney disease (ckd) is substantial and derives from numerous aggregating cardiovascular risk factors [1]. |
| PubMedID- 21382989 | Background: secondary hyperparathyroidism is a common complication of chronic kidney disease (ckd) that is associated with bone disease, cardiovascular disease and death. |
| PubMedID- 22749861 | Aims: proteinuria is an independent risk factor for cardiovascular disease (cvd) in patients with chronic kidney disease (ckd). |
| PubMedID- 25530222 | The use of vitamin d receptor activators (vdras) is an independent predictor of a lower risk of death from cardiovascular disease (cvd) in patients with chronic kidney disease (ckd). |
| PubMedID- 21625102 | Cardiovascular disease is increased in patients with chronic kidney disease (ckd) and is the principle cause of morbidity and mortality in these patients. |
| PubMedID- 24489988 | Systemic inflammation and oxidative stress are nontraditional risk factors that are associated with premature cardiovascular disease commonly observed in patients with chronic kidney disease (ckd) [1, 2]. |
| PubMedID- 24084210 | Reduced nitric oxide bioavailability contributes to increased cardiovascular disease risk in patients with chronic kidney disease (ckd). |
Page: 1